Welcome to Servier Australia

More information about the Servier Group

The latest from the Newsroom

Breaking the Silence:

Mental Health Awareness Day 2024

Breaking the Silence: Mental Health Awareness Day 2024

24/10/2024

Roadmap to 70% Blood Pressure Control in Australia by 2030

09/10/2024

Confident Conversations

10/07/2024

The Kosi Challenge – Climbing to Support Rare Cancers Australia

17/05/2024

21,400

Employees

150+

Countries in which
the Group’s medicines
are distributed

20％

Over 20% of revenue from
brand-name medicines invested
in R&D each year

€ 4.9 billion

in revenue in 2021/2022
including €3.7 billion for brand-name medicines and
€1.2 billion for generic activities

4 therapeutic areas

Oncology,
Neuroscience,
Immuno-inflammation, and
Cardio-metabolism

Latest from Socials

Servier Australia 07/06/2024 Facebook

We are delighted to announce that Servier Australia has been awarded the Great Place to Work Certification for the year 2024, marking this the fourth consecutive year!

A massive congratulations and thank you to all our colleagues for their contributions to this significant achievement!

Click here to see this post.

Servier Australia 17/03/2024 LinkedIn

Yesterday we stepped up to the challenge, rolled up our sleeves and put in a great effort to collect nearly 10 bags of rubbish from our local office park and surrounds.

We will continue to reduce our waste every day and work towards a cleaner and greener Australia ♻️

Click here to see this post.

Servier Australia 02/05/2024 LinkedIn

Last week, we gathered in Melbourne to reconnect as a team, celebrate achievements, and reflect on future perspectives towards our Servier 2030 vision. Under the theme of ‘Growth Mindset’, and a focus on ‘People, Patients, Planet’, there was a high level of energy and engagement though group discussions and sharing sessions.

Click here to see this post.